These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 37026250)

  • 21. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
    Xiao W; Xu GT; Zhang J; Zhang J; Zhang Y; Ye W
    Exp Eye Res; 2015 Sep; 138():145-52. PubMed ID: 26187517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Severity of Diabetic Retinopathy Corresponds with Corneal Nerve Alterations and Ocular Discomfort of the Patient.
    Machalińska A; Kuligowska A; Ziontkowska-Wrzałek A; Stroynowska B; Pius-Sadowska E; Safranow K; Machaliński J; Mozolewska-Piotrowska K; Machaliński B
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.
    Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA;
    Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capsanthin from Capsicum annum fruits exerts anti-glaucoma, antioxidant, anti-inflammatory activity, and corneal pro-inflammatory cytokine gene expression in a benzalkonium chloride-induced rat dry eye model.
    Shanmugham V; Subban R
    J Food Biochem; 2022 Oct; 46(10):e14352. PubMed ID: 35892258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tear proteomics in dry eye disease.
    Kannan R; Das S; Shetty R; Zhou L; Ghosh A; Deshpande V
    Indian J Ophthalmol; 2023 Apr; 71(4):1203-1214. PubMed ID: 37026251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dry Eye Disease and Tear Cytokine Levels-A Meta-Analysis.
    Roda M; Corazza I; Bacchi Reggiani ML; Pellegrini M; Taroni L; Giannaccare G; Versura P
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lacrimal and meibomian gland evaluation in dry eye disease: A mini-review.
    Singh S; Donthineni PR; Srivastav S; Jacobi C; Basu S; Paulsen F
    Indian J Ophthalmol; 2023 Apr; 71(4):1090-1098. PubMed ID: 37026239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of video display terminal use and meibomian gland dysfunction on the ocular surface and tear neuromediators.
    Bilgic AA; Kocabeyoglu S; Dikmetas O; Tan C; Karakaya J; Irkec M
    Int Ophthalmol; 2023 May; 43(5):1537-1544. PubMed ID: 36239837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tear film inflammatory cytokine upregulation in contact lens discomfort.
    Gad A; Vingrys AJ; Wong CY; Jackson DC; Downie LE
    Ocul Surf; 2019 Jan; 17(1):89-97. PubMed ID: 30321605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease.
    Liu R; Gao C; Chen H; Li Y; Jin Y; Qi H
    PLoS One; 2017; 12(4):e0173301. PubMed ID: 28379971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Nondiabetes With Dry Eye.
    Liu R; Ma B; Gao Y; Ma B; Liu Y; Qi H
    Am J Ophthalmol; 2019 Apr; 200():10-15. PubMed ID: 30552892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).
    Hu B; Qiu Y; Hong J
    Ocul Surf; 2020 Apr; 18(2):298-304. PubMed ID: 31954196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of tear film biomarkers in the diagnosis and management of dry eye disease.
    Fong PY; Shih KC; Lam PY; Chan TCY; Jhanji V; Tong L
    Taiwan J Ophthalmol; 2019; 9(3):150-159. PubMed ID: 31572651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.
    Wei Y; Gadaria-Rathod N; Epstein S; Asbell P
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8327-36. PubMed ID: 24204044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.